A new DRUG TRIALS SNAPSHOT is now available.
XADAGO is a drug for the treatment of “off episodes” in patients with Parkinson’s disease (PD). XADAGO is to be added to drugs for the treatment of Parkinson’s disease that contain levodopa/carbidopa combination.
An “off” episode” is a time when a patient’s medications are not working well, leading to an increase in Parkinson’s symptoms, such as tremor and difficulty walking.
See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.